Last reviewed · How we verify

NCT05470634: TAKOHA

Trail-running After Knee or Hip Arthroplasty

Completed Last updated 9 January 2023
What this trial tests

trial in Arthropathy of Knee in 31 participants. Completed in 15 September 2022.

Timeline
15 July 2022
Primary endpoint
15 September 2022
15 September 2022

Quick facts

Lead sponsorCentre Hospitalier Universitaire de la Réunion
StatusCompleted
Study typeOBSERVATIONAL
Enrollment31
Start date15 July 2022
Primary completion15 September 2022
Estimated completion15 September 2022
Sites1 location across Reunion

Conditions studied

Sponsor

Centre Hospitalier Universitaire de la Réunion

Who can join

18 and older, any sex, with Arthropathy of Knee or Arthropathy of Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The incidence of indications for hip and knee arthroplasty is constantly increasing due to an increase in arthrogenic risk factors and life expectancy. In younger patients, with a higher functional demand, resumption of physical activity and sport is a major objective after resumption of walking and pain management. The repercussions of returning to sports after arthroplasty have been widely studied in the literature. Few studies have looked specifically at high-impact activities, the possibility of resuming sport and its consequences. The recommendations are essentially based on expert opinion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Arthropathy of Knee

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de la Réunion trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05470634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing